SEARCH

SEARCH BY CITATION

References

  • Alme B, Sjovall J (1980). Analysis of bile acid glucuronides in urine. Identification of 3 alpha, 6 alpha, 12 alpha-trihydroxy-5 beta-cholanoic acid. J Steroid Biochem 13 (8): 907916.
  • Alme B, Bremmelgaard A, Sjovall J, Thomassen P (1977). Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry. J Lipid Res 18 (3): 339362.
  • Alvaro D, Gigliozzi A, Marucci L, Alpini G, Barbaro B, Monterubbianesi R et al. (2002). Corticosteroids modulate the secretory processes of the rat intrahepatic biliary epithelium. Gastroenterology 122 (4): 10581069.
  • Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ (2001). Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276 (31): 2885728865.
  • Araya Z, Wikvall K (1999). 6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochim Biophys Acta 1438 (1): 4754.
  • Arenas F, Hervias I, Uriz M, Joplin R, Prieto J, Medina JF (2008). Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. J Clin Invest 118 (2): 695709.
  • Arrese M, Karpen SJ (2002). HNF-1 alpha: have bile acid transport genes found their ‘master’? J Hepatol 36 (1): 142145.
  • Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G et al. (2004). Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 279 (21): 2225022257.
  • Axon A, Cowie DE, Mann DA, Wright MC (2008). A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver: Inhibition of NF-kappaB? Toxicology 246 (1): 4044.
  • Bachs L, Pares A, Elena M, Piera C, Rodes J (1989). Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet 1 (8638): 574576.
  • Bachs L, Pares A, Elena M, Piera C, Rodes J (1992). Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 102 (6): 20772080.
  • Barbier O, Duran-Sandoval D, Pineda-Torra I, Kosykh V, Fruchart JC, Staels B (2003a). Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme. J Biol Chem 278 (35): 3285232860.
  • Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D et al. (2003b). FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124 (7): 19261940.
  • Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J et al. (2006). A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355 (22): 22972307.
  • Berge Henegouwen GP, Brandt KH, Eyssen H, Parmentier G (1976). Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis. Gut 17 (11): 861869.
  • Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M et al. (1998). Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 95 (21): 1220812213.
  • Bloomer JR, Boyer JL (1975). Phenobarbital effects in cholestatic liver diseases. Ann Intern Med 82 (3): 310317.
  • Bodin K, Lindbom U, Diczfalusy U (2005). Novel pathways of bile acid metabolism involving CYP3A4. Biochim Biophys Acta 1687 (1–3): 8493.
  • Bohan A, Chen WS, Denson LA, Held MA, Boyer JL (2003). Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J Biol Chem 278 (38): 3668836698.
  • Bremmelgaard A, Sjovall J (1979). Bile acid profiles in urine of patients with liver diseases. Eur J Clin Invest 9 (5): 341348.
  • Bremmelgaard A, Sjovall J (1980). Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis. J Lipid Res 21 (8): 10721081.
  • Brown JD, Plutzky J (2007). Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 115 (4): 518533.
  • Caldwell SH, Argo CK, Al-Osaimi AM (2006). Therapy of NAFLD: insulin sensitizing agents. J Clin Gastroenterol 40 (3 Suppl. 1): S61S66.
  • Campbell MJ, Adorini L (2006). The vitamin D receptor as a therapeutic target. Expert Opin Ther Targets 10 (5): 735748.
  • Cancado EL, Leitao RM, Carrilho FJ, Laudanna AA (1998). Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase. Am J Gastroenterol 93 (9): 15101517.
  • Carrella M, Feldman D, Cogoi S, Csillaghy A, Weinhold PA (1999). Enhancement of mdr2 gene transcription mediates the biliary transfer of phosphatidylcholine supplied by an increased biosynthesis in the pravastatin-treated rat. Hepatology 29 (6): 18251832.
  • Castillo-Olivares A, Gil G (2000). Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha-hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. J Biol Chem 275 (23): 1779317799.
  • Chatterjee B, Echchgadda I, Song CS (2005). Vitamin D receptor regulation of the steroid/bile acid sulfotransferase SULT2A1. Methods Enzymol 400: 165191.
  • Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ (2001). Nuclear receptors and lipid physiology: opening the X-files. Science 294 (5548): 18661870.
  • Chen C, Staudinger JL, Klaassen CD (2003a). Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab Dispos 31 (7): 908915.
  • Chen F, Ma L, Dawson PA, Sinal CJ, Sehayek E, Gonzalez FJ et al. (2003b). Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J Biol Chem 278 (22): 1990919916.
  • Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely AS et al. (2004). Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 126 (3): 756764.
  • Chen W, Chiang JY (2003). Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). Gene 313: 7182.
  • Chen X, Chen F, Liu S, Glaeser H, Dawson PA, Hofmann AF et al. (2006). Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor. Mol Pharmacol 69 (6): 19131923.
  • Cheng X, Buckley D, Klaassen CD (2007). Regulation of hepatic bile acid transporters Ntcp and Bsep expression. Biochem Pharmacol 74 (11): 16651676.
  • Cherrington NJ, Hartley DP, Li N, Johnson DR, Klaassen CD (2002). Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 300 (1): 97104.
  • Chianale J, Vollrath V, Wielandt AM, Amigo L, Rigotti A, Nervi F et al. (1996). Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem J 314 (Pt 3): 781786.
  • Chiang JY (1998). Regulation of bile acid synthesis. Front Biosci 3: d176d193.
  • Chiang JY (2004). Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 40 (3): 539551.
  • Chiang JY, Kimmel R, Weinberger C, Stroup D (2000). Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Biol Chem 275 (15): 1091810924.
  • Chiang JY, Kimmel R, Stroup D (2001). Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 262 (1–2): 257265.
  • Cindoruk M, Kerem M, Karakan T, Salman B, Akin O, Alper M et al. (2007). Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study. BMC Gastroenterol 7: 44.
  • Courtois A, Payen L, Guillouzo A, Fardel O (1999). Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone. FEBS Lett 459 (3): 381385.
  • Courtois A, Payen L, Le Ferrec E, Scheffer GL, Trinquart Y, Guillouzo A et al. (2002). Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. Biochem Pharmacol 63 (2): 333341.
  • Cullen SN, Chapman RW (2006). The medical management of primary sclerosing cholangitis. Semin Liver Dis 26 (1): 5261.
  • Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV et al. (2005). The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 280 (8): 69606968.
  • De Fabiani E, Mitro N, Anzulovich AC, Pinelli A, Galli G, Crestani M (2001). The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276 (33): 3070830716.
  • De Fabiani E, Mitro N, Gilardi F, Caruso D, Galli G, Crestani M (2003). Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle. J Biol Chem 278 (40): 3912439132.
  • Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ et al. (2001). The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121 (1): 140147.
  • Dhe-Paganon S, Duda K, Iwamoto M, Chi YI, Shoelson SE (2002). Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem 277 (41): 3797337976.
  • Ding X, Lichti K, Kim I, Gonzalez FJ, Staudinger JL (2006). Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha. J Biol Chem 281 (36): 2654026551.
  • Donner MG, Keppler D (2001). Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34 (2): 351359.
  • Dubuquoy L, Dharancy S, Nutten S, Pettersson S, Auwerx J, Desreumaux P (2002). Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360 (9343): 14101418.
  • Echchgadda I, Song CS, Roy AK, Chatterjee B (2004). Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 65 (3): 720729.
  • Echchgadda I, Song CS, Oh T, Ahmed M, De La Cruz IJ, Chatterjee B (2007). The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-/bile acid-sulfotransferase. Mol Endocrinol 21 (9): 20992111.
  • Edwards PA, Kast HR, Anisfeld AM (2002). BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res 43 (1): 212.
  • Ellis E, Wagner M, Lammert F, Nemeth A, Gumhold J, Strassburg CP et al. (2006). Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin. J Hepatol 44 (1): 243245.
  • Eloranta JJ, Kullak-Ublick GA (2005). Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 433 (2): 397412.
  • Eloranta JJ, Jung D, Kullak-Ublick GA (2006). The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-{gamma} coactivator-1{alpha}, and suppressed by bile acids via a small heterodimer partner-dependent mechanism. Mol Endocrinol 20 (1): 6579.
  • Falany CN (1997). Enzymology of human cytosolic sulfotransferases. FASEB J 11 (4): 206216.
  • Falkner KC, Pinaire JA, Xiao GH, Geoghegan TE, Prough RA (2001). Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. Mol Pharmacol 60 (3): 611619.
  • Fang HL, Strom SC, Cai H, Falany CN, Kocarek TA, Runge-Morris M (2005). Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Mol Pharmacol 67 (4): 12571267.
  • Fayard E, Auwerx J, Schoonjans K (2004). LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol 14 (5): 250260.
  • Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R et al. (2001). Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 121 (1): 170183.
  • Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F et al. (2002). Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123 (4): 12381251.
  • Finck BN, Kelly DP (2006). PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116 (3): 615622.
  • Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L et al. (2004). The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 127 (5): 14971512.
  • Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour BM et al. (2005a). Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J Pharmacol Exp Ther 313 (2): 604612.
  • Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L et al. (2005b). Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. J Pharmacol Exp Ther 315 (1): 5868.
  • Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L et al. (2005c). A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J Pharmacol Exp Ther 314 (2): 584595.
  • Frankenberg T, Rao A, Chen F, Haywood J, Shneider BL, Dawson PA (2006). Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. Am J Physiol Gastrointest Liver Physiol 290 (5): G912G922.
  • Frohling W, Stiehl A (1976). Bile salt glucuronides: identification and quantitative analysis in the urine of patients with cholestasis. Eur J Clin Invest 6: 6774.
  • Funk C, Ponelle C, Scheuermann G, Pantze M (2001). Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 59 (3): 627635.
  • Gall WE, Zawada G, Mojarrabi B, Tephly TR, Green MD, Coffman BL et al. (1999). Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 70 (1–3): 101108.
  • Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G et al. (2002). Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 122 (7): 19241940.
  • Gascon-Barre M, Demers C, Mirshahi A, Neron S, Zalzal S, Nanci A (2003). The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 37 (5): 10341042.
  • Gerloff T, Geier A, Roots I, Meier PJ, Gartung C (2002). Functional analysis of the rat bile salt export pump gene promoter. Eur J Biochem 269 (14): 34953503.
  • Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, Willson TM et al. (2007). Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol Cell 25 (1): 5770.
  • Ghose R, Zimmerman TL, Thevananther S, Karpen SJ (2004). Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2 (1): 4.
  • Ghose R, Mulder J, Von Furstenberg RJ, Thevananther S, Kuipers F, Karpen SJ (2007). Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver. J Hepatol 46 (1): 115123.
  • Glass CK, Rosenfeld MG (2000). The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14 (2): 121141.
  • Gnerre C, Blattler S, Kaufmann MR, Looser R, Meyer UA (2004). Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics 14 (10): 635645.
  • Gong H, Singh SV, Singh SP, Mu Y, Lee JH, Saini SP et al. (2006). Orphan nuclear receptor pregnane X receptor sensitizes oxidative stress responses in transgenic mice and cancerous cells. Mol Endocrinol 20 (2): 279290.
  • Goodwin B, Moore JT (2004). CAR: detailing new models. Trends Pharmacol Sci 25 (8): 437441.
  • Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB et al. (2000). A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6 (3): 517526.
  • Goodwin B, Hodgson E, D'Costa DJ, Robertson GR, Liddle C (2002a). Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol 62 (2): 359365.
  • Goodwin B, Redinbo MR, Kliewer SA (2002b). Regulation of cyp3a gene transcription by the pregnane x receptor. Annu Rev Pharmacol Toxicol 42: 123.
  • Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA (2003). Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol 17 (3): 386394.
  • Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB, Jr, Kliewer SA et al. (2003). Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 278 (46): 4506245071.
  • Handschin C, Meyer UA (2003). Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 55 (4): 649673.
  • Haughton EL, Tucker SJ, Marek CJ, Durward E, Leel V, Bascal Z et al. (2006). Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology 131 (1): 194209.
  • Hertz R, Magenheim J, Berman I, Bar-Tana J (1998). Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392 (6675): 512516.
  • Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T et al. (1998). Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Mol Pharmacol 53 (6): 10681075.
  • Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF et al. (2003). Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17 (13): 15811591.
  • Honjo Y, Sasaki S, Kobayashi Y, Misawa H, Nakamura H (2006). 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor. J Endocrinol 188 (3): 635643.
  • Hooiveld GJ, Vos TA, Scheffer GL, Van Goor H, Koning H, Bloks V et al. (1999). 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats. Gastroenterology 117 (3): 678687.
  • Huang L, Zhao A, Lew JL, Zhang T, Hrywna Y, Thompson JR et al. (2003a). Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J Biol Chem 278 (51): 5108551090.
  • Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R et al. (2003b). Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci USA 100 (7): 41564161.
  • Huang W, Zhang J, Moore DD (2004). A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest 113 (1): 137143.
  • Huang W, Zhang J, Washington M, Liu J, Parant JM, Lozano G et al. (2005). Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol 19 (6): 16461653.
  • Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J et al. (2006). Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312 (5771): 233236.
  • Huss JM, Kasper CB (1998). Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression. J Biol Chem 273 (26): 1615516162.
  • Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG et al. (2005). Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2 (4): 217225.
  • Inagaki T, Moschetta A, Lee YK, Peng L, Zhao G, Downes M et al. (2006). Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci USA 103 (10): 39203925.
  • Inokuchi A, Hinoshita E, Iwamoto Y, Kohno K, Kuwano M, Uchiumi T (2001). Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. J Biol Chem 276 (50): 4682246829.
  • Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996). An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383 (6602): 728731.
  • Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P (2003). Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9 (2): 213219.
  • Jung D, Kullak-Ublick GA (2003). Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression. Hepatology 37 (3): 622631.
  • Jung D, Fried M, Kullak-Ublick GA (2002). Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha. J Biol Chem 277 (34): 3055930566.
  • Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA (2004a). Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 53 (1): 7884.
  • Jung D, Hagenbuch B, Fried M, Meier PJ, Kullak-Ublick GA (2004b). Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am J Physiol Gastrointest Liver Physiol 286 (5): G752G761.
  • Kamisako T, Adachi Y (1995). Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis. Am J Gastroenterol 90 (7): 11871188.
  • Kamiya A, Inoue Y, Gonzalez FJ (2003). Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology 37 (6): 13751384.
  • Kanda T, Yokosuka O, Imazeki F, Saisho H (2003). Bezafibrate treatment: a new medical approach for PBC patients? J Gastroenterol 38 (6): 573578.
  • Karpen SJ (2002). Nuclear receptor regulation of hepatic function. J Hepatol 36 (6): 832850.
  • Karpen SJ (2005). Exercising the nuclear option to treat cholestasis: CAR and PXR ligands. Hepatology 42 (2): 266269.
  • Karpen SJ, Sun AQ, Kudish B, Hagenbuch B, Meier PJ, Ananthanarayanan M et al. (1996). Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. J Biol Chem 271 (25): 1521115221.
  • Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM et al. (2002). Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277 (4): 29082915.
  • Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D et al. (2005). Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 41 (5): 11601172.
  • Kim HI, Koh YK, Kim TH, Kwon SK, Im SS, Choi HS et al. (2007a). Transcriptional activation of SHP by PPAR-gamma in liver. Biochem Biophys Res Commun 360 (2): 301306.
  • Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL et al. (2007b). Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48 (12): 26642672.
  • Kim I, Morimura K, Shah Y, Yang Q, Ward JM, Gonzalez FJ (2007c). Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28 (5): 940946.
  • Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C (2003). Repression of farnesoid X receptor during the acute phase response. J Biol Chem 278 (11): 89888995.
  • King CD, Rios GR, Green MD, Tephly TR (2000). UDP-glucuronosyltransferases. Curr Drug Metab 1 (2): 143161.
  • Kok T, Bloks VW, Wolters H, Havinga R, Jansen PL, Staels B et al. (2003). Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 369 (Pt 3): 539547.
  • Kota BP, Huang TH, Roufogalis BD (2005). An overview on biological mechanisms of PPARs. Pharmacol Res 51 (2): 8594.
  • Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA et al. (2005). Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120 (3): 343355.
  • Kubitz R, Wettstein M, Warskulat U, Haussinger D (1999). Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116 (2): 401410.
  • Kullak-Ublick GA, Stieger B, Hagenbuch B, Meier PJ (2000). Hepatic transport of bile salts. Semin Liver Dis 20 (3): 273292.
  • Kumar R, Johnson BH, Thompson EB (2004). Overview of the structural basis for transcription regulation by nuclear hormone receptors. Essays Biochem 40: 2739.
  • Kurihara T, Akimoto M, Abe K, Ishiguro H, Niimi A, Maeda A et al. (1993). Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia. Clin Ther 15 (5): 890898.
  • Kurihara T, Niimi A, Maeda A, Shigemoto M, Yamashita K (2000). Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid. Am J Gastroenterol 95 (10): 29902992.
    Direct Link:
  • Kurihara T, Maeda A, Shigemoto M, Yamashita K, Hashimoto E (2002). Investigation into the efficacy of bezafibrate against primary biliary cirrhosis, with histological references from cases receiving long term monotherapy. Am J Gastroenterol 97 (1): 212214.
    Direct Link:
  • Ladias JA, Hadzopoulou-Cladaras M, Kardassis D, Cardot P, Cheng J, Zannis V et al. (1992). Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J Biol Chem 267 (22): 1584915860.
  • Laffitte BA, Tontonoz P (2002). Orphan nuclear receptors find a home in the arterial wall. Curr Atheroscler Rep 4 (3): 213221.
  • Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, Edwards PA (2000). Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem 275 (14): 1063810647.
  • Landrier JF, Thomas C, Grober J, Duez H, Percevault F, Souidi M et al. (2004). Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent. J Biol Chem 279 (44): 4551245518.
  • Landrier JF, Eloranta JJ, Vavricka SR, Kullak-Ublick GA (2006). The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. Am J Physiol Gastrointest Liver Physiol 290 (3): G476G485.
  • Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y (2006a). FXR, a multipurpose nuclear receptor. Trends Biochem Sci 31 (10): 572580.
  • Lee H, Zhang Y, Lee FY, Nelson SF, Gonzalez FJ, Edwards PA (2006b). FXR regulates organic solute transporter alpha and beta in the adrenal gland, kidney and intestine. J Lipid Res 47: 201214.
  • Lee WM (2003). Drug-induced hepatotoxicity. N Engl J Med 349 (5): 474485.
  • Lee YK, Dell H, Dowhan DH, Hadzopoulou-Cladaras M, Moore DD (2000). The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol Cell Biol 20 (1): 187195.
  • Lee YK, Schmidt DR, Cummins CL, Choi M, Peng L, Zhang Y et al. (2008). Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol 2008 (6): 13451356.
  • Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL et al. (1997). Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272 (6): 31373140.
  • Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102 (5): 10161023.
  • Leuschner M, Guldutuna S, You T, Hubner K, Bhatti S, Leuschner U (1996). Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol 25 (1): 4957.
  • Leuschner M, Maier KP, Schlichting J, Strahl S, Herrmann G, Dahm HH et al. (1999). Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology 117 (4): 918925.
  • Lew JL, Zhao A, Yu J, Huang L, De Pedro N, Pelaez F et al. (2004). The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. J Biol Chem 279 (10): 88568861.
  • Li D, Zimmerman TL, Thevananther S, Lee HY, Kurie JM, Karpen SJ (2002). Interleukin-1 beta-mediated suppression of RXR : RAR transactivation of the Ntcp promoter is JNK-dependent. J Biol Chem 277 (35): 3141631422.
  • Li J, Ning G, Duncan SA (2000). Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 14 (4): 464474.
  • Li T, Chiang JY (2005). Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. Am J Physiol Gastrointest Liver Physiol 288 (1): G74G84.
  • Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J et al. (2000). Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6 (3): 507515.
  • Lu TT, Repa JJ, Mangelsdorf DJ (2001). Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem 276 (41): 3773537738.
  • Lutjohann D, Hahn C, Prange W, Sudhop T, Axelson M, Sauerbruch T et al. (2004). Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men. Int J Clin Pharmacol Ther 42 (6): 307313.
  • McCarthy TC, Li X, Sinal CJ (2005). Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem 280 (24): 2323223242.
  • McKenna NJ, Lanz RB, O'Malley BW (1999). Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20 (3): 321344.
  • Maher JM, Cheng X, Slitt AL, Dieter MZ, Klaassen CD (2005). Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 33 (7): 956962.
  • Makino I, Hashimoto H, Shinozaki K, Yoshino K, Nakagawa S (1975). Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases. Gastroenterology 68 (3): 545553.
  • Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM et al. (2002). Vitamin D receptor as an intestinal bile acid sensor. Science 296 (5571): 13131316.
  • Mangelsdorf DJ, Evans RM (1995). The RXR heterodimers and orphan receptors. Cell 83 (6): 841850.
  • Marek CJ, Tucker SJ, Konstantinou DK, Elrick LJ, Haefner D, Sigalas C et al. (2005). Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem J 387 (Pt 3): 601608.
  • Marra F, DeFranco R, Robino G, Novo E, Efsen E, Pastacaldi S et al. (2005). Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J Gastroenterol 11 (32): 49314938.
  • Marrapodi M, Chiang JY (2000). Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Lipid Res 41 (4): 514520.
  • Marschall HU, Wagner M, Zollner G, Fickert P, Diczfalusy U, Gumhold J et al. (2005). Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129 (2): 476485.
  • Marschall HU, Wagner M, Bodin K, Zollner G, Fickert P, Gumhold J et al. (2006). Fxr(−/−) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J Lipid Res 47 (3): 582592.
  • Mataki C, Magnier BC, Houten SM, Annicotte JS, Argmann C, Thomas C et al. (2007). Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol Cell Biol 27 (23): 83308339.
  • Matsumura K, Saito T, Takahashi Y, Ozeki T, Kiyotani K, Fujieda M et al. (2004). Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol Pharmacol 65 (2): 326334.
  • Miquerol L, Lopez S, Cartier N, Tulliez M, Raymondjean M, Kahn A (1994). Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J Biol Chem 269 (12): 89448951.
  • Miranda S, Vollrath V, Wielandt AM, Loyola G, Bronfman M, Chianale J (1997). Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver. J Hepatol 26 (6): 13311339.
  • Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OF (1992). A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol 15 (3): 336344.
  • Miura N, Tanaka K (1993). Analysis of the rat hepatocyte nuclear factor (HNF) 1 gene promoter: synergistic activation by HNF4 and HNF1 proteins. Nucleic Acids Res 21 (16): 37313736.
  • Miura T, Ouchida R, Yoshikawa N, Okamoto K, Makino Y, Nakamura T et al. (2001). Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid. J Biol Chem 276 (50): 4737147378.
  • Moreau A, Vilarem MJ, Maurel P, Pascussi JM (2008). Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol Pharm 5 (1): 3541.
  • Moschetta A, Bookout AL, Mangelsdorf DJ (2004). Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 10 (12): 13521358.
  • Myant NB, Mitropoulos KA (1977). Cholesterol 7 alpha-hydroxylase. J Lipid Res 18 (2): 135153.
  • Nakai S, Masaki T, Kurokohchi K, Deguchi A, Nishioka M (2000). Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study. Am J Gastroenterol 95 (1): 326327.
    Direct Link:
  • Nakata K, Tanaka Y, Nakano T, Adachi T, Tanaka H, Kaminuma T et al. (2006). Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. Drug Metab Pharmacokinet 21 (6): 437457.
  • Nishihara E, O'Malley BW, Xu J (2004). Nuclear receptor coregulators are new players in nervous system development and function. Mol Neurobiol 30 (3): 307325.
  • Nishimura M, Koeda A, Suzuki E, Kawano Y, Nakayama M, Satoh T et al. (2006). Regulation of mRNA expression of MDR1, MRP1, MRP2 and MRP3 by prototypical microsomal enzyme inducers in primary cultures of human and rat hepatocytes. Drug Metab Pharmacokinet 21 (4): 297307.
  • Nitta M, Ku S, Brown C, Okamoto AY, Shan B (1999). CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene. Proc Natl Acad Sci USA 96 (12): 66606665.
  • Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL et al. (2004). Control of pancreas and liver gene expression by HNF transcription factors. Science 303 (5662): 13781381.
  • Ogawa K, Suzuki H, Hirohashi T, Ishikawa T, Meier PJ, Hirose K et al. (2000). Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 278 (3): G438G446.
  • Ogino M, Nagata K, Miyata M, Yamazoe Y (1999). Hepatocyte nuclear factor 4-mediated activation of rat CYP3A1 gene and its modes of modulation by apolipoprotein AI regulatory protein I and v-ErbA-related protein 3. Arch Biochem Biophys 362 (1): 3237.
  • Ohmoto K, Mitsui Y, Yamamoto S (2001). Effect of bezafibrate in primary biliary cirrhosis: a pilot study. Liver 21 (3): 223224.
  • Oiwa A, Kakizawa T, Miyamoto T, Yamashita K, Jiang W, Takeda T et al. (2007). Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1. Biochem Biophys Res Commun 353 (4): 895901.
  • Ortlund EA, Lee Y, Solomon IH, Hager JM, Safi R, Choi Y et al. (2005). Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP. Nat Struct Mol Biol 12 (4): 357363.
  • Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y et al. (2001). Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 98 (11): 60276032.
  • Oude Elferink RP, Paulusma CC, Groen AK (2006). Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology 130 (3): 908925.
  • Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA et al. (1999). Bile acids: natural ligands for an orphan nuclear receptor. Science 284 (5418): 13651368.
  • Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V et al. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437 (7059): 759763.
  • Pascussi JM, Drocourt L, Fabre JM, Maurel P, Vilarem MJ (2000). Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 58 (2): 361372.
  • Pascussi JM, Gerbal-Chaloin S, Drocourt L, Maurel P, Vilarem MJ (2003). The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619 (3): 243253.
  • Patel DD, Knight BL, Soutar AK, Gibbons GF, Wade DP (2000). The effect of peroxisome-proliferator-activated receptor-alpha on the activity of the cholesterol 7 alpha-hydroxylase gene. Biochem J 351 (Pt 3): 747753.
  • Paumgartner G, Pusl T (2008). Medical treatment of cholestatic liver disease. Clin Liver Dis 12 (1): 5380.
  • Pellicciari R, Costantino G, Fiorucci S (2005). Farnesoid X receptor: from structure to potential clinical applications. J Med Chem 48 (17): 53835403.
  • Pellicoro A, Faber KN (2007). Review article: the function and regulation of proteins involved in bile salt biosynthesis and transport. Aliment Pharmacol Ther 26 (Suppl. 2): 149160.
  • Perissi V, Rosenfeld MG (2005). Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6 (7): 542554.
  • Pikuleva IA, Babiker A, Waterman MR, Bjorkhem I (1998). Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J Biol Chem 273 (29): 1815318160.
  • Pineda TI, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B (2003). Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol 17 (2): 259272.
  • Pineda Torra I, Jamshidi Y, Flavell DM, Fruchart JC, Staels B (2002). Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Mol Endocrinol 16 (5): 10131028.
  • Plass JR, Mol O, Heegsma J, Geuken M, Faber KN, Jansen PL et al. (2002). Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35 (3): 589596.
  • Post SM, Duez H, Gervois PP, Staels B, Kuipers F, Princen HM (2001). Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 21 (11): 18401845.
  • Prieto J, Qian C, Garcia N, Diez J, Medina JF (1993). Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 105 (2): 572578.
  • Prince MI, Burt AD, Jones DE (2002). Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut 50 (3): 436439.
  • Pulaski L, Kania K, Ratajewski M, Uchiumi T, Kuwano M, Bartosz G (2005). Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids. J Steroid Biochem Mol Biol 96 (3–4): 229234.
  • Rautiainen H, Karkkainen P, Karvonen AL, Nurmi H, Pikkarainen P, Nuutinen H et al. (2005). Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial. Hepatology 41 (4): 747752.
  • Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ (2002). Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277 (21): 1879318800.
  • Ritzel U, Leonhardt U, Nather M, Schafer G, Armstrong VW, Ramadori G (2002). Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers. J Hepatol 36 (4): 454458.
  • Roglans N, Vazquez-Carrera M, Alegret M, Novell F, Zambon D, Ros E et al. (2004). Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. Eur J Clin Pharmacol 59 (12): 855861.
  • Rudling M, Angelin B, Stahle L, Reihner E, Sahlin S, Olivecrona H et al. (2002). Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver. J Clin Endocrinol Metab 87 (9): 43074313.
  • Runge-Morris M, Wu W, Kocarek TA (1999). Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcriptional control. Mol Pharmacol 56 (6): 11981206.
  • Saini SP, Sonoda J, Xu L, Toma D, Uppal H, Mu Y et al. (2004). A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol Pharmacol 65 (2): 292300.
  • Saini SP, Mu Y, Gong H, Toma D, Uppal H, Ren S et al. (2005). Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. Hepatology 41 (3): 497505.
  • Scholtes C, Diaz O, Icard V, Kaul A, Bartenschlager R, Lotteau V et al. (2008). Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. J Hepatol 48 (2): 192199.
  • Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C et al. (2001). Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 276 (42): 3941139418.
  • Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ et al. (2001). Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27 (4): 375382.
  • Shoda J, Tanaka N, Osuga T, Matsuura K, Miyazaki H (1990). Altered bile acid metabolism in liver disease: concurrent occurrence of C-1 and C-6 hydroxylated bile acid metabolites and their preferential excretion into urine. J Lipid Res 31 (2): 249259.
  • Shoda J, Kano M, Oda K, Kamiya J, Nimura Y, Suzuki H et al. (2001). The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 96 (12): 33683378.
    Direct Link:
  • Shoda J, Inada Y, Tsuji A, Kusama H, Ueda T, Ikegami T et al. (2004). Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4. J Lipid Res 45 (10): 18131825.
  • Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ (2000). Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102 (6): 731744.
  • Sladek FM (1994). Hepatocyte Nuclear Factor 4. R.G. Landes Company, Austin, TX.
  • Sladek FM, Zhong WM, Lai E, Darnell JE, Jr. (1990). Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4 (12B): 23532365.
  • Snow KL, Moseley RH (2007). Effect of thiazolidinediones on bile acid transport in rat liver. Life Sci 80 (8): 732740.
  • Song C, Hiipakka RA, Liao S (2000). Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 65 (8): 423427.
  • Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK et al. (2001). Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J Biol Chem 276 (45): 4254942556.
  • Song X, Kaimal R, Yan B, Deng R (2008). Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression. J Lipid Res (5): 973984.
  • Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, Evans RM (2002). Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 99 (21): 1380113806.
  • Soroka CJ, Lee JM, Azzaroli F, Boyer JL (2001). Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33 (4): 783791.
  • Squires EJ, Sueyoshi T, Negishi M (2004). Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J Biol Chem 279 (47): 4930749314.
  • Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD (2001a). Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos 29 (11): 14671472.
  • Staudinger JL (2008). Liver-enriched nuclear receptors: therapeutic opportunities. Mol Pharm 5 (1): 12.
  • Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A et al. (2001b). The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98 (6): 33693374.
  • Stedman C, Robertson G, Coulter S, Liddle C (2004). Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice. J Biol Chem 279 (12): 1133611343.
  • Stedman C, Liddle C, Coulter S, Sonoda J, Alvarez JG, Evans RM et al. (2006). Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc Natl Acad Sci USA 103 (30): 1132311328.
  • Stiehl A, Thaler MM, Admirand WH (1972). The effects of phenobarbital on bile salts and bilirubin in patients with intrahepatic and extrahepatic cholestasis. N Engl J Med 286 (16): 858861.
  • Stojakovic T, Putz-Bankuti C, Fauler G, Scharnagl H, Wagner M, Stadlbauer V et al. (2007). Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology 46 (3): 776784.
  • Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H et al. (1998). A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 20 (3): 233238.
  • Stroup D, Crestani M, Chiang JY (1997). Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A. Am J Physiol 273 (2 Pt 1): G508G517.
  • Szatmari I, Vamosi G, Brazda P, Balint BL, Benko S, Szeles L et al. (2006). Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J Biol Chem 281 (33): 2381223823.
  • Takeda K, Ichiki T, Tokunou T, Funakoshi Y, Iino N, Hirano K et al. (2000). Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells. Circulation 102 (15): 18341839.
  • Tall AR, Costet P, Luo Y (2000). Orphans' meet cholesterol. Nat Med 6 (10): 11041105.
  • Tanaka H, Makino I (1992). Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor. Biochem Biophys Res Commun 188 (2): 942948.
  • Tanaka Y, Kobayashi Y, Gabazza EC, Higuchi K, Kamisako T, Kuroda M et al. (2002). Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol Gastrointest Liver Physiol 282 (4): G656G662.
  • Teng S, Piquette-Miller M (2005). The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312 (2): 841848.
  • Teng S, Piquette-Miller M (2007). Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol 151 (3): 367376.
  • Teng S, Jekerle V, Piquette-Miller M (2003). Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab Dispos 31 (11): 12961299.
  • Thomassen PA (1979). Urinary bile acids in late pregnancy and in recurrent cholestasis of pregnancy. Eur J Clin Invest 9 (6): 425432.
  • Tian JM, Schibler U (1991). Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes Dev 5 (12A): 22252234.
  • Tirona RG, Kim RB (2005). Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94 (6): 11691186.
  • Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V et al. (2003). The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9 (2): 220224.
  • Trauner M, Boyer JL (2003). Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83 (2): 633671.
  • Trauner M, Meier PJ, Boyer JL (1998). Molecular pathogenesis of cholestasis. N Engl J Med 339 (17): 12171227.
  • Trottier J, Verreault M, Grepper S, Monte D, Belanger J, Kaeding J et al. (2006). Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver. Hepatology 44 (5): 11581170.
  • Turncliff RZ, Meier PJ, Brouwer KL (2004). Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug Metab Dispos 32 (8): 834839.
  • Turunen MM, Dunlop TW, Carlberg C, Vaisanen S (2007). Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res 35 (8): 27342747.
  • Uppal H, Toma D, Saini SP, Ren S, Jones TJ, Xie W (2005). Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice. Hepatology 41 (1): 168176.
  • Uppal H, Saini SP, Moschetta A, Mu Y, Zhou J, Gong H et al. (2007). Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology 45 (2): 422432.
  • Van Mil SW, Milona A, Dixon PH, Mullenbach R, Geenes VL, Chambers J et al. (2007). Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 133 (2): 507516.
  • Verreault M, Senekeo-Effenberger K, Trottier J, Bonzo JA, Belanger J, Kaeding J et al. (2006). The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice. Hepatology 44 (2): 368378.
  • Wagner M, Fickert P, Zollner G, Fuchsbichler A, Silbert D, Tsybrovskyy O et al. (2003). Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125 (3): 825838.
  • Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C et al. (2005). CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42 (2): 420430.
  • Wang B, Cai SR, Gao C, Sladek FM, Ponder KP (2001). Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4 alpha in rat liver. Hepatology 34 (5): 979989.
  • Wang L, Lee YK, Bundman D, Han Y, Thevananther S, Kim CS et al. (2002). Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2 (6): 721731.
  • Wang W, Zhang C, Marimuthu A, Krupka HI, Tabrizizad M, Shelloe R et al. (2005). The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc Natl Acad Sci USA 102 (21): 75057510.
  • Warskulat U, Kubitz R, Wettstein M, Stieger B, Meier PJ, Haussinger D (1999). Regulation of bile salt export pump mRNA levels by dexamethasone and osmolarity in cultured rat hepatocytes. Biol Chem 380 (11): 12731279.
  • Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C, Raftogianis RB (1997). Sulfation and sulfotransferases 1: sulfotransferase molecular biology: cDNAs and genes. FASEB J 11 (1): 314.
  • Westin S, Heyman RA, Martin R (2005). FXR, a therapeutic target for bile acid and lipid disorders. Mini Rev Med Chem 5 (8): 719727.
  • Willson TM, Brown PJ, Sternbach DD, Henke BR (2000). The PPARs: from orphan receptors to drug discovery. J Med Chem 43 (4): 527550.
  • Wilson FA, Burckhardt G, Murer H, Rumrich G, Ullrich KJ (1981). Sodium-coupled taurocholate transport in the proximal convolution of the rat kidney in vivo and in vitro. J Clin Invest 67 (4): 11411150.
  • Wisely GB, Miller AB, Davis RG, Thornquest AD, Jr, Johnson R, Spitzer T et al. (2002). Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 10 (9): 12251234.
  • Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES et al. (2001). An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98 (6): 33753380.
  • Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS et al. (2003). Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 100 (7): 41504155.
  • Xie W, Uppal H, Saini SP, Mu Y, Little JM, Radominska-Pandya A et al. (2004). Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. Drug Discov Today 9 (10): 442449.
  • Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ et al. (1996). Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384 (6608): 458460.
  • Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64 (20): 71977200.
  • Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W (2007). Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res 67 (3): 863867.
  • Yang Y, Zhang M, Eggertsen G, Chiang JY (2002). On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha. Biochim Biophys Acta 1583 (1): 6373.
  • Yano K, Kato H, Morita S, Takahara O, Ishibashi H, Furukawa R (2002). Is bezafibrate histologically effective for primary biliary cirrhosis? Am J Gastroenterol 97 (4): 10751077.
    Direct Link:
  • Yerushalmi B, Sokol RJ, Narkewicz MR, Smith D, Karrer FM (1999). Use of rifampin for severe pruritus in children with chronic cholestasis. J Pediatr Gastroenterol Nutr 29 (4): 442447.
  • Zelcer N, Tontonoz P (2006). Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116 (3): 607614.
  • Zhang J, Huang W, Qatanani M, Evans RM, Moore DD (2004a). The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J Biol Chem 279 (47): 4951749522.
  • Zhang M, Chiang JY (2001). Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression. J Biol Chem 276 (45): 4169041699.
  • Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA (2004b). Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 18 (2): 157169.
  • Zollner G, Trauner M (2006). Molecular mechanisms of cholestasis. Wien Med Wochenschr 156 (13–14): 380385.
  • Zollner G, Trauner M (2008). Mechanisms of cholestasis. Clin Liver Dis 12 (1): 126.
  • Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L et al. (2001). Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33 (3): 633646.
  • Zollner G, Fickert P, Fuchsbichler A, Silbert D, Wagner M, Arbeiter S et al. (2003a). Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol 39 (4): 480488.
  • Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K et al. (2003b). Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 38 (6): 717727.
  • Zollner G, Wagner M, Fickert P, Geier A, Fuchsbichler A, Silbert D et al. (2005). Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Am J Physiol Gastrointest Liver Physiol 289: G798G805.
  • Zollner G, Fickert P, Silbert D, Fuchsbichler A, Wagner M, Guo GL et al. (2006a). Role of nuclear bile salt receptors FXR and PXR in mediating adaptive hepatobiliary transporter response to cholic acid (CA) in mouse liver [Abstract. Gastroenterology 24: (Suppl. 1): A59.
  • Zollner G, Marschall HU, Wagner M, Trauner M (2006b). Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3 (3): 231251.
  • Zollner G, Wagner M, Moustafa T, Fickert P, Silbert D, Gumhold J et al. (2006c). Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-{alpha}/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol 290 (5): G923G932.
  • Zollner G, Wagner M, Fickert P, Silbert D, Gumhold J, Zatloukal K et al. (2007). Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int 27 (7): 920929.